Skip to main content
Mayinglong Pharmaceutical Group Co.,Ltd logo

Mayinglong Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 600993 ISIN · CNE000001HN2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 931 across all filing types
Latest filing 2013-05-20 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 600993

About Mayinglong Pharmaceutical Group Co.,Ltd

https://www.mayinglong.cn/

Mayinglong Pharmaceutical Group Co.,Ltd. is a long-established enterprise specializing in the research, development, and production of Traditional Chinese Medicine (TCM). Founded in 1582, the company is widely recognized for its expertise in proctology, maintaining a dominant market position with its signature hemorrhoid ointments and suppositories. Its product portfolio also includes ophthalmic preparations, dermatological treatments, and gastrointestinal medicines. The company integrates traditional medicinal formulas with modern manufacturing technologies to provide healthcare solutions. Beyond pharmaceuticals, Mayinglong has expanded into healthcare services, including specialized hospitals and personal care products, focusing on the integration of clinical treatment and health management.

Recent filings

Filing Released Lang Actions
第八届监事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolution from the first meeting of the eighth supervisory board of the company, including the election of the chairman of the supervisory board. It contains no financial data, no report or presentation, and no mention of voting results or dividends. It is a formal announcement related to board/management information, specifically about the supervisory board's composition and leadership. Therefore, it fits best under Board/Management Information (MANG). The document length is short and it is not a report publication or certification, so it is not RPA or RNS.
2013-05-20 Chinese
2012年年度股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as the 2012 Annual General Meeting (AGM) materials for 马应龙药业集团股份有限公司. It contains detailed agenda items for the AGM, including the review and approval of the Board of Directors' report, Supervisory Board report, Independent Directors' report, financial statements, profit distribution plan, and election of board members. The content includes detailed reports and financial data for the year 2012, which are typical components of AGM materials. The document is lengthy (15,000 characters) and contains substantive content rather than just an announcement or a brief summary. Therefore, it fits the category of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting.
2013-05-12 Chinese
独立董事关于相关事项的独立意见
Board/Management Information Classification · 90% confidence The document is an independent opinion statement from independent directors regarding various company matters including the 2012 annual profit distribution plan, board election nominations, internal control self-evaluation, director remuneration adjustments, and company guarantees. It references the 2012 annual report but does not contain the report itself or detailed financial statements. The document is a formal opinion related to governance and compliance matters rather than a full annual report or financial statement. It is not a brief announcement or certification but a detailed governance-related opinion. Therefore, it fits best under Board/Management Information (MANG) as it discusses board nominations and related governance opinions.
2013-04-24 Chinese
2012年度独立董事述职报告
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Annual Report" for the year 2012 from a pharmaceutical company. It details the independent directors' activities, attendance at board and shareholder meetings, their opinions on company governance, internal controls, related party transactions, and other oversight functions during the year. It does not contain financial statements or detailed financial performance data but rather focuses on governance and oversight activities by independent directors. This type of document is a report on board/management information, specifically about independent directors' duties and evaluations. It is not an annual report (10-K), audit report, or earnings release. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length is under 5,000 characters, but it is a substantive report, not just an announcement of a report, so it is not RPA or RNS.
2013-04-24 Chinese
2012年度内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled as the "2012年度内部控制自我评价报告" which translates to "2012 Annual Internal Control Self-Evaluation Report". It is a detailed report on the company's internal control system, its evaluation, and effectiveness for the fiscal year ending December 31, 2012. The content includes governance structure, risk assessment, control activities, internal audit, and conclusions on internal control effectiveness. It is a comprehensive internal control report rather than a general annual report or audit report. This type of document aligns with the category of Audit Report / Information (AR), which includes standalone audit reports and internal control evaluations. The document length is over 10,000 characters, indicating it is a full report, not just an announcement or certification. Therefore, the appropriate classification is AR with high confidence. FY 2012
2013-04-24 Chinese
2012年年度审计报告
Audit Report / Information Classification · 100% confidence The document is an audit report issued by a certified public accounting firm for the fiscal year ending December 31, 2012. It includes the auditor's responsibilities, management's responsibilities, and the auditor's opinion on the financial statements of the company. The content is typical of a standalone audit report rather than a full annual report or other filing types. The document length is short (1007 characters), but it contains the full audit opinion and related statements, not just an announcement or certification. Therefore, it fits the category of Audit Report / Information (AR).
2013-04-24 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.